ab14056 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab14056 は 21 報の論文で使用されています。

  • Sato S  et al. Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity. Respir Res 18:172 (2017). PubMed: 28915889
  • Tong JG  et al. Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential. BMC Cancer 17:594 (2017). PubMed: 28854921
  • Tong JG  et al. Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasis. Mol Ther Oncolytics 2:15013 (2015). WB . PubMed: 27119108
  • Rojek A  et al. Liver-specific Aquaporin 11 knockout mice show rapid vacuolization of the rough endoplasmic reticulum in periportal hepatocytes after amino acid feeding. Am J Physiol Gastrointest Liver Physiol 304:G501-15 (2013). Mouse . PubMed: 23275615
  • Du F  et al. Novel Domain Interaction Regulates Secretion of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Protein. J Biol Chem 286:43054-61 (2011). PubMed: 22027821
  • Li H & Liu J Identification of heterogeneous nuclear ribonucleoprotein K as a transactivator for human low density lipoprotein receptor gene transcription. J Biol Chem 285:17789-97 (2010). WB ; Human . PubMed: 20371611
  • Li H  et al. Identification of mRNA-binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements. J Lipid Res : (2009). PubMed: 19141871
  • Holla ØL  et al. Nonsense-mediated decay of human LDL receptor mRNA. Scand J Clin Lab Invest 69:409-17 (2009). WB ; Human . PubMed: 19148831
  • Kang Q & Chen A Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells. Br J Pharmacol 157:1354-67 (2009). WB ; Rat . PubMed: 19594758
  • Fan D  et al. Self-association of human PCSK9 correlates with its LDLR-degrading activity. Biochemistry 47:1631-9 (2008). PubMed: 18197702
  • Poirier S  et al. The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2. J Biol Chem 283:2363-72 (2008). WB ; Human . PubMed: 18039658
  • Lee SM  et al. GCG-Rich Tea Catechins are Effective in Lowering Cholesterol and Triglyceride Concentrations in Hyperlipidemic Rats. Lipids 43:419-29 (2008). WB ; Rat . PubMed: 18365267
  • Loeper S  et al. Ikaros modulates cholesterol uptake: a link between tumor suppression and differentiation. Cancer Res 68:3715-23 (2008). WB ; Mouse . PubMed: 18483254
  • Vargas NB  et al. Protein kinase C activation stabilizes LDL receptor mRNA via the JNK pathway in HepG2 cells. J Lipid Res : (2008). WB ; Human . PubMed: 18936517
  • Chen Y  et al. Inflammatory cytokines disrupt LDL-receptor feedback regulation and cause statin resistance: a comparative study in human hepatic cells and mesangial cells. Am J Physiol Renal Physiol 293:F680-7 (2007). WB ; Human . PubMed: 17634396
  • Morral N  et al. Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver. J Lipid Res 48:1499-510 (2007). WB ; Rat . PubMed: 17449907
  • Qian YW  et al. Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis. J Lipid Res 48:1488-98 (2007). WB ; Human . PubMed: 17449864
  • Nassoury N  et al. The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR. Traffic 8:718-32 (2007). ICC/IF . PubMed: 17461796
  • Whitaker HC  et al. Labeling and identification of LNCaP cell surface proteins: a pilot study. Prostate 67:943-54 (2007). PubMed: 17440980
  • Grozdanov PN  et al. Expression and localization of PCSK9 in rat hepatic cells. Biochem Cell Biol 84:80-92 (2006). PubMed: 16462892
  • Poirier S  et al. Implication of the proprotein convertase NARC-1/PCSK9 in the development of the nervous system. J Neurochem 98:838-50 (2006). PubMed: 16893422